|
|
|
|
|
|
|
|
|
|
Rv3795 More about Rv3795 on TBDB.org More about Rv3795 on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv3795: all mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Srivastava S CurrMicro 2006 | GTC/GGG | 383 | 128 | Val/Gly | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 5ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Jain A IndJMedRes 2008 | GCG/GGC | 662-663 | 221 | Ala/Gly | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Jain A IndJMedRes 2008 | GCG/AGC | 673-674 | 225 | Ala/Ser | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Jain A IndJMedRes 2008 | GTG/GGC | 680-681 | 227 | Val/Gly | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Srivastava S CurrMicro 2006 | CTC/CCC | 716 | 239 | Leu/Pro | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 256ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Srivastava S CurrMicro 2006 | GAC/CAC | 718 | 240 | Asp/His | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 4ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Srivastava S JMM 2009 | CGT/TGG | 769-771 | 257 | Arg/Trp | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embC V287F, Y309N; embR A176V, R230W, I369T" | - |
| Jain A IndJMedRes 2008 | GCG/GTG | 812 | 271 | Ala/Val | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Jain A IndJMedRes 2008 | AGC/TGC | 814 | 272 | Ser/Cys | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Jain A IndJMedRes 2008 | AGC/ATT | 815-816 | 272 | Ser/Ile | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Wu X Chinese J of Antibiotics 2002 | CGC/CCC | 821 | 274 | Arg/Pro | - | - | - | - | - | - | - | - | - | - | - |
| Jain A IndJMedRes 2008 | GCG/CCG | 841 | 281 | Ala/Pro | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Jain A IndJMedRes 2008 | TTT/CTG | 841-843 | 281 | Phe/Leu | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Srivastava S JMM 2009 | GTG/GGG | 845 | 282 | Val/Gly | Published 2009 | India | Sequencing | Whole gene | EHR | 12ug/ml | Proportion method, E-Test | 44/44 | 1/0 | None in region embB, embC or embR' | - |
| Jain A IndJMedRes 2008 | GTG/CTG | 844 | 282 | Val/Leu | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Sreevatsan S AAC 1997 | TTC/TTA | 855 | 285 | Phe/Leu | Published 1997 | USA, Mexico, Europe, Yemen, the Philippines, Japan, India | PCR-SSCP, Sequencing | Whole gene | E | N.S. | BACTEC 460, agar diffusion method | 69/99 | 1/0 | - | - |
| Jain A IndJMedRes 2008 | TTT/TGC | 860-861 | 287 | Phe/Cys | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Jain A IndJMedRes 2008 | TTT/GTG | 859-861 | 287 | Phe/Val | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Jain A IndJMedRes 2008 | ATT/AAC | 878-879 | 293 | Ile/Asn | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Jain A IndJMedRes 2008 | GGC/AGC | 880 | 294 | Gly/Ser | 2002-2004 | India | Sequencing | ERDR | EHRS | >20ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Srivastava S JMM 2009 | AAT/AAA | 888 | 296 | Asn/Lys | Published 2009 | India | Sequencing | Whole gene | EHR | 16ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB E368D, G406S; embC I297T" | - |
| Ramaswamy SV AAC 2000 | TCG/GCG | 889 | 297 | Ser/Ala | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 10-50ug/ml | BACTEC 460, agar diffusion method | 75/108 | 1/0 | - | - |
| Plinke C AAC 2006 | TCG/TTG | 890 | 297 | Ser/Leu | 2001 | Germany | Sequencing | ERDR | E + INH + RIF | N.S. | Proportion method, BACTEC 460 | 101/159 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Srivastava S CurrMicro 2006 | GAC/GAA | 897 | 299 | Asp/Glu | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 2-6ug/ml | Proportion method, E-Test | 23/23 | 4/0 | "Out of 4 isolates, 2 were WT in all other loci analyzed except for a synonymous mutation (GCA/GCC) at embB259. These isolates had MIC=4-6ug/ml. Both other isolates contained the embB mutation Glu378Ala (GAA/GCG); one of them was also mutated at embB Pro44" | - |
| Sreevatsan S AAC 1997 | ATG/CTG | 916 | 306 | Met/Leu | Published 1997 | USA, Mexico, Europe, Yemen, the Philippines, Japan, India | PCR-SSCP, Sequencing | Whole gene | E | 40ug/ml | BACTEC 460, agar diffusion method | 69/99 | 1/0 | - | ![]() |
| Lee HY YonseiMedJ 2002 | ATG/TTG | 916 | 306 | Met/Leu | Published 2002 | South Korea | Sequencing | Whole gene | E, | 2ug/ml | Proportion method | 21/26 | 1/0 | None in region amplified (see Gene coverage). | - |
| Sreevatsan S AAC 1997 | ATG/GTG | 916 | 306 | Met/Val | Published 1997 | USA, Mexico, Europe, Yemen, the Philippines, Japan, India | PCR-SSCP, Sequencing | Whole gene | E | 40ug/ml | BACTEC 460, agar diffusion method | 69/99 | 12/0 | - | ![]() |
| Sreevatsan S AAC 1997 | ATG/ATA | 918 | 306 | Met/Ile | Published 1997 | USA, Mexico, Europe, Yemen, the Philippines, Japan, India | PCR-SSCP, Sequencing | Whole gene | E | 20ug/ml | BACTEC 460, agar diffusion method | 69/99 | 11/0 | - | ![]() |
| Sreevatsan S AAC 1997 | ATG/ATT | 918 | 306 | Met/Ile | Published 1997 | USA, Mexico, Europe, Yemen, the Philippines, Japan, India | PCR-SSCP, Sequencing | Whole gene | E | 20ug/ml | BACTEC 460, agar diffusion method | 69/99 | 2/0 | - | ![]() |
| Sreevatsan S AAC 1997 | ATG/ATC | 918 | 306 | Met/Ile | Published 1997 | USA, Mexico, Europe, Yemen, the Philippines, Japan, India | PCR-SSCP, Sequencing | Whole gene | E | 20ug/ml | BACTEC 460, agar diffusion method | 69/99 | 3/0 | - | ![]() |
| Lee HY YonseiMedJ 2002 | ATG/ACG | 917-918 | 306 | Met/Thr | Published 2002 | South Korea | Sequencing | ERDR | E | 2ug/ml | Proportion method | 21/26 | 1/0 | None in region amplified (see Gene coverage). | - |
| Srivastava S JMM 2009 | GTG/GGC | 926-927 | 309 | Val/Gly | Published 2009 | India | Sequencing | Whole gene | EHR | 128ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306V, A310R, D311R, V369A, P375A, F398Y, P461S; embC T270I; embR G240R" | - |
| Srivastava S JMM 2009 | GCG/CGT | 928-930 | 310 | Ala/Arg | Published 2009 | India | Sequencing | Whole gene | EHR | 128ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306V, V309G, D311R, V369A, P375A, F398Y, P461S; embC T270I; embR G240R" | - |
| Srivastava S JMM 2009 | GAC/CGT | 931-932 | 311 | Asp/Arg | Published 2009 | India | Sequencing | Whole gene | EHR | 128ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306V, V309G, A310R, V369A, P375A, F398Y, P461S; embC T270I; embR G240R" | - |
| Srivastava S CurrMicro 2006 | GAC/CAC | 931 | 311 | Asp/His | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 12ug/ml | Proportion method, E-Test | 23/23 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Srivastava S JMM 2009 | CAT/CGT | 935 | 312 | His/Arg | Published 2009 | India | Sequencing | Whole gene | EHR | 96ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB S317T, A356F, L359I, R367P; embC G288V, M310K, Y327N" | - |
| Lee HY YonseiMedJ 2002 | GGC/GCG | 941 | 314 | Gly/Ala | Published 2002 | South Korea | Sequencing | ERDR | E | 4ug/ml | Proportion method | 21/26 | 1/0 | Tyr322Cys on embB. | - |
| Tracevska T ResMicro 2004 | GGC/GAG | 941-942 | 314 | Gly/Glu | "Published 2004; isolates collected in 2001-2002" | Latvia | Sequencing | ERDR | EHRS | N.S. | BACTEC radiorespiratory method (7.5ug/ml EMB), and absolute concentration method on L-J medium (cutoff 2.0ug/ml EMB) | 33/66 | 1/0 | None in region amplified (see Gene coverage). | - |
| Srivastava S JMM 2009 | TAT/CTG | 943-945 | 315 | Tyr/Leu | Published 2009 | India | Sequencing | Whole gene | EHR | 256ug/ml | Proportion method, E-Test | 44/44 | 1/0 | embB L239P, N318S, V377G, E378A, Y384N, N400K, V452L | - |
| Srivastava S JMM 2009 | AGC/ACC | 950 | 317 | Ser/Thr | Published 2009 | India | Sequencing | Whole gene | EHR | 96ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB H312R, A356F, L359I, R367P; embC G288V, M310K, Y327N" | - |
| Srivastava S JMM 2009 | AAC/CAT | 352 | 318 | Asn/His | Published 2009 | India | Sequencing | Whole gene | EHR | 16ug/ml | Proportion method, E-Test | 44/44 | 1/0 | embC T270I | - |
| Srivastava S JMM 2009 | AAC/AGC | 953 | 318 | Asn/Ser | Published 2009 | India | Sequencing | Whole gene | EHR | 256ug/ml | Proportion method, E-Test | 44/44 | 1/0 | embB L239P, Y315L, V377G, E378A, Y384N, N400K, V452L | - |
| Srivastava S JMM 2009 | AAC/AAA | 954 | 318 | Asn/Lys | Published 2009 | India | Sequencing | Whole gene | EHR | 32ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306V, N368A, S380R, P397Q, G459A, R460C; embR T32P, D53H" | - |
| Sugawara I Jpn J Infect Dis 2005 | TAT/GAT | 955 | 319 | Tyr/Cys | - | - | - | - | - | - | - | - | - | - | - |
| Chan RCY JAC 2007 | TAT/AAT | 955 | 319 | Tyr/Asn | - | - | - | - | - | - | - | - | - | - | - |
| Sugawara I Jpn J Infect Dis 2005 | TAT/TGT | 956 | 319 | Tyr/Cys | - | - | - | - | - | - | - | - | - | - | - |
| Plinke C AAC 2006 | TAT/TCT | 956 | 319 | Tyr/Ser | 2001 | Germany | Sequencing | ERDR | EHR | N.S. | Proportion method, BACTEC 460 | 101/159 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Lee HY YonseiMedJ 2002 | TAT/TGT | 965 | 322 | Tyr/Cys | Published 2002 | South Korea | Sequencing | ERDR | E | 4ug/ml | Proportion method | 21/26 | 1/0 | Ala314Gly on embB. | - |
| Ramaswamy SV AAC 2000 | GAT/TAT | 982 | 328 | Asp/Tyr | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 30ug/ml | BACTEC 460, agar diffusion method | 75/108 | 1/0 | Ala201Thr in embA, Tyr334His in embB. | - |
| Ramaswamy SV AAC 2000 | GAT/GGT | 983 | 328 | Asp/Gly | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 10-50ug/ml | BACTEC 460, agar diffusion method | 75/108 | 1/0 | - | - |
| Plinke C AAC 2006 | GAT/GTG | 983-984 | 328 | Asp/Val | 2001 | Germany | Sequencing | ERDR | EHR | N.S. | Proportion method, BACTEC 460 | 101/159 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Escalante P TuberLung Dis 1998 | del A | 983 | - | Frameshift | "Published 1998; isolates collected 1995-1996" | Peru | Sequencing | ERDR | E | N.S. | Proportion method | 40146 | 1/0 | None in region amplified (see Gene coverage). | - |
| Sreevatsan S AAC 1997 | TTC/GTC | 988 | 330 | Phe/Val | Published 1997 | USA, Mexico, Europe, Yemen, the Philippines, Japan, India | PCR-SSCP, Sequencing | Whole gene | E | 40ug/ml | BACTEC 460, agar diffusion method | 69/99 | 1/0 | - | - |
| Srivastava S JMM 2009 | GGC/CGT | 991-993 | 331 | Gly/Arg | Published 2009 | India | Sequencing | Whole gene | ER | 16ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB V360M, G374V, G401S; embC I297T; embR D223E" | - |
| Lee HY YonseiMedJ 2002 | GAT/TAT | 991 | 331 | Asp/Tyr | Published 2002 | Korea | Sequencing | ERDR | E | 4ug/ml | Proportion method | 21/26 | 1/0 | None in region amplified (see Gene coverage). | - |
| Plinke C AAC 2006 | TGG/CTG | 994-995 | 332 | Trp/Leu | 2001 | Germany | Sequencing | ERDR | EHR | N.S. | Proportion method, BACTEC 460 | 101/159 | 1/0 | None in region amplified (see Gene coverage). R/Tot and R/S calculated from Table 1. | - |
| Sugawara I Jpn J Infect Dis 2005 | TAT/CAT | 997 | 333 | Tyr/His | - | - | - | - | - | - | - | - | - | - | - |
| Ramaswamy SV AAC 2000 | TAC/CAC | 1000 | 334 | Tyr/His | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 30ug/ml | BACTEC 460, agar diffusion method | 75/108 | 1/0 | Ala201Thr in embA, Asp328Tyr in embB. | - |
| Escalante P TuberLung Dis 1998 | AGT/ACT | 1040 | 347 | Ser/Thr | "Published 1998; isolates collected 1995-1996" | Peru | Sequencing | ERDR | E | N.S. | Proportion method | 40146 | 1/0 | None in region amplified (see Gene coverage). | - |
| Srivastava S JMM 2009 | AGT/ATT | 1040 | 347 | Ser/Ile | Published 2009 | India | Sequencing | Whole gene | EHR | 4ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB E368D, R460L; embC I297T; embR R230W, I396T" | - |
| Srivastava S JMM 2009 | GCG/TTT | 1066-1068 | 356 | Ala/Phe | Published 2009 | India | Sequencing | Whole gene | EHR | 96ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB H312R, S317T, L359I, R367P; embC G288V, M310K, Y327N" | - |
| Srivastava S JMM 2009 | GCG/AGC | 1066-1068 | 356 | Ala/Ser | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB D299E, P371R, E378K; embR R230W, L292M, L303E" | - |
| Srivastava S JMM 2009 | GCG/GTG | 1067 | 356 | Ala/Val | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306L, S366P, W395R, A434G, V435G, V436G, T437A; embC T270I" | - |
| Srivastava S JMM 2009 | GCG/AGC | 1069-1071 | 357 | Ala/Ser | Published 2009 | India | Sequencing | Whole gene | EHR | 2ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB A379T; embC V287F, Y309N; embR L320V S326N, V350G, H351Q, R356G, I369T" | - |
| Srivastava S JMM 2009 | GCG/GTG | 1070 | 357 | Ala/Val | Published 2009 | India | Sequencing | Whole gene | EHR | 8ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB A356F, L359I, E378A, A379D, Y384N, A388G, N399D, G406P; embC A247P, T270I, I297T" | - |
| Srivastava S JMM 2009 | GGC/GTG | 1073-1074 | 358 | Gly/Val | Published 2009 | India | Sequencing | Whole gene | EHR | 3ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB E368Q, S380D, P397T, G406D, G448V; embC I287L, W326R" | - |
| Srivastava S JMM 2009 | CTG/ATT | 1075-1077 | 359 | Leu/Ile | Published 2009 | India | Sequencing | Whole gene | EHR | 96ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB H312R, S317T, A356F, R367P; embC G288V, M310K, Y327N" | - |
| Srivastava S JMM 2009 | GTG/ATG | 1078 | 360 | Val/Met | Published 2009 | India | Sequencing | Whole gene | ER | 16ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB G331R, G374V, G401S; embC I297T; embR D223E" | - |
| Srivastava S JMM 2009 | AGC/CCG | 1096 | 366 | Ser/Pro | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306L, A356V, W395R, A434G, V435G, V436G, T437A; embC T270I" | - |
| Srivastava S JMM 2009 | CGT/CCG | 1100-1101 | 367 | Arg/Pro | Published 2009 | India | Sequencing | Whole gene | EHR | 96ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB H312R, S317T, A356F, L359I; embC G288V, M310K, Y327N" | - |
| Srivastava S JMM 2009 | GAA/CAG | 1102-1104 | 368 | Glu/Gln | Published 2009 | India | Sequencing | Whole gene | EHR | 3ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB G358V, S380D, P397T, G406D, G448V; embC I287L, W326R" | - |
| Srivastava S JMM 2009 | GAA/GAT | 1104 | 368 | Glu/Asp | Published 2009 | India | Sequencing | Whole gene | EHR | 4ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB S347I, R460L; embC I297T; embR R230W, I396T" | - |
| Srivastava S CurrMicro 2006 | GAA/GCG | 1103-1104 | 368 | Glu/Ala | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 32ug/ml | Proportion method | 23/23 | 1/0 | Met306Val, Ser380Arg, and Pro397Gln on embB. | - |
| Srivastava S JMM 2009 | GTG/CTG | 1105 | 369 | Val/Leu | Published 2009 | India | Sequencing | Whole gene | EHR | 12ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306I; embC L251R, A354G, T270I" | - |
| Srivastava S JMM 2009 | GTG/GCG | 1106 | 369 | Val/Ala | Published 2009 | India | Sequencing | Whole gene | EHR | 128ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306V, V309G, A310R, D311R, P375A, F398Y, P461S; embC T270I; embR G240R" | - |
| Srivastava S JMM 2009 | CTG/CGT | 1109-1110 | 370 | Leu/Arg | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | embB V377M, E378A, F398H, N399H, E405P, G406A | - |
| Srivastava S JMM 2009 | CCG/CGT | 1112-1113 | 371 | Pro/Arg | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB D299E, A356S, E378K; embR R230W, L292M, L303E" | - |
| Srivastava S JMM 2009 | GGC/GTG | 1121-1122 | 374 | Gly/Val | Published 2009 | India | Sequencing | Whole gene | EH | 4ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embC W395C, N400P; embC G288W, V303G; embR A187V, R230W, I369T" | - |
| Srivastava S JMM 2009 | CCG/GCG | 1123-1124 | 375 | Pro/Ala | Published 2009 | India | Sequencing | Whole gene | EHR | 128ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306V, V309G, A310R, D311R, V369A, F398Y, P461S; embC T270I; embR G240R" | - |
| Srivastava S JMM 2009 | GTG/ATG | 1129 | 377 | Val/Met | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | embB L370R, E378A, F398H, N399H, E405P, G406A | - |
| Srivastava S JMM 2009 | GTG/GGC | 1130-1131 | 377 | Val/Gly | Published 2009 | India | Sequencing | Whole gene | EHR | 256ug/ml | Proportion method, E-Test | 44/44 | 1/0 | embB L239P, Y315L, N318S, E378A, Y384N, N400K, V452L | - |
| Srivastava S JMM 2009 | GAA/AAA | 1132 | 378 | Glu/Lys | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB D299E, A356S, P371R; embR R230W, L292M, L303E" | - |
| Srivastava S CurrMicro 2006 | GAA/GCG | 1103-1104 | 378 | Glu/Ala | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 2ug/ml | Proportion method | 23/23 | 2/0 | Both of these isolates were mutated at embB Asp299Glu. One was also mutated at embB Pro446His and Ile465Asp, as well as embC Thr270Ile and 254 Synonymous (GCC/GCG). The other isolate was mutated at embBArg469Pro and Arg 471Pro. R/Tot and R/S calculated fr | - |
| Srivastava S JMM 2009 | GCG/ACC | 1135-1137 | 379 | Ala/Thr | Published 2009 | India | Sequencing | Whole gene | EHR | 2ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB A357S; embC V287F, Y309N; embR L320V S326N, V350G, H351Q, R356G, I369T" | - |
| Srivastava S JMM 2009 | GCG/GAT | 1136-1137 | 379 | Ala/Asp | Published 2009 | India | Sequencing | Whole gene | EHR | 8ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB A356F, A357V, L359I, E378A, Y384N, A388G, N399D, G406P; embC A247P, T270I, I297T" | - |
| Srivastava S CurrMicro 2006 | AGC/CGT | 1138-1140 | 380 | Ser/Arg | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 32ug/ml | Proportion method | 23/23 | 1/0 | Met306Val, Glu368Ala, and Pro397Gln on embB. R/Tot and R/S calculated from Table 1. | - |
| Srivastava S JMM 2009 | AGC/AAC | 1139 | 380 | Ser/Asp | Published 2009 | India | Sequencing | Whole gene | EHR | 3ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB G358V, E368Q, P397T, G406D, G448V; embC I287L, W326R" | - |
| Srivastava S JMM 2009 | TAT/AAC | 1150-1152 | 384 | Tyr/Asn | Published 2009 | India | Sequencing | Whole gene | EHR | 256ug/ml | Proportion method, E-Test | 44/44 | 1/0 | embB L239P, Y315L, N318S, V377G, E378A, N400K, V452L | - |
| Srivastava S JMM 2009 | GCG/GGC | 1163-1164 | 388 | Ala/Gly | Published 2009 | India | Sequencing | Whole gene | EHR | 8ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB A356F, A357V, L359I, E378A, A379D, Y384N, N399D, G406P; embC A247P, T270I, I297T" | - |
| Srivastava S JMM 2009 | TGG/CGT | 1183-1185 | 395 | Trp/Arg | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306L, A356V, S366P, A434G, V435G, V436G, T437A; embC T270I" | - |
| Srivastava S JMM 2009 | TGG/TGC | 1185 | 395 | Trp/Cys | Published 2009 | India | Sequencing | Whole gene | EH | 4ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embC G374V, N400P; embC G288W, V303G; embR A187V, R230W, I369T" | - |
| Srivastava S JMM 2009 | CCG/ACC | 1189-1190 | 397 | Pro/Thr | Published 2009 | India | Sequencing | Whole gene | EHR | 3ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB G358V, E368Q, S380D, G406D, G448V; embC I287L, W326R" | - |
| Srivastava S CurrMicro 2006 | CCG/CAG | 1190 | 397 | Pro/Gln | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 32ug/ml | Proportion method | 23/23 | 1/0 | Met306Val, Glu368Ala, and Ser380Arg on embB. R/Tot and R/S calculated from Table 1. | - |
| Srivastava S JMM 2009 | TTT/CAT | 1192-1193 | 398 | Phe/His | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | embB L370R, V377M, E378A, N399H, E405P, G406A | - |
| Srivastava S JMM 2009 | TTT/TAT | 1193 | 398 | Phe/Tyr | Published 2009 | India | Sequencing | Whole gene | EHR | 128ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306V, V309G, A310R, D311R, V369A, P375A, P461S; embC T270I; embR G240R" | - |
| Srivastava S JMM 2009 | TTT/GAT | 1195-1196 | 399 | Asn/Asp | Published 2009 | India | Sequencing | Whole gene | EHR | 8ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB A356F, A357V, L359I, E378A, A379D, Y384N, A388G, G406P; embC A247P, T270I, I297T" | - |
| Srivastava S JMM 2009 | TTT/CAT | 1195-1196 | 399 | Asn/His | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | embB L370R, V377M, E378A, F398H, E405P, G406A | - |
| Srivastava S JMM 2009 | AAC/CCG | 1198-1200 | 400 | Asn/Pro | Published 2009 | India | Sequencing | Whole gene | EH | 4ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embC G374V, W395C; embC G288W, V303G; embR A187V, R230W, I369T" | - |
| Srivastava S JMM 2009 | AAC/AAA | 1200 | 400 | Asn/Lys | Published 2009 | India | Sequencing | Whole gene | EHR | 256ug/ml | Proportion method, E-Test | 44/44 | 1/0 | embB L239P, Y315L, N318S, E378A, Y384N, V452L | - |
| Srivastava S JMM 2009 | ACG/ACA | 1203 | 401 | Gly/Ser | Published 2009 | India | Sequencing | Whole gene | ER | 16ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB G331R, G374V, G374V; embC I297T; embR D223E" | - |
| Srivastava S JMM 2009 | GAA/CCG | 1213-1214 | 405 | Glu/Pro | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | embB L370R, V377M, E378A, F398H, N399H, G406A | - |
| Srivastava S JMM 2009 | GGC/CCG | 1216 | 406 | Gly/Pro | Published 2009 | India | Sequencing | Whole gene | EHR | 8ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB A356F, A357V, L359I, E378A, A379D, Y384N, A388G, N399D; embC A247P, T270I, I297T" | - |
| Ramaswamy SV AAC 2000 | GGC/AGC | 1216 | 406 | Gly/Ser | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 30ug/ml | BACTEC 460, agar diffusion method | 75/108 | 1/0 | -43 CG deletion in embA. | ![]() |
| Ramaswamy SV AAC 2000 | GGC/TGC | 1216 | 406 | Gly/Cys | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 30-50ug/ml | BACTEC 460, agar diffusion method | 75/108 | 2/0 | - | - |
| Srivastava S JMM 2009 | GGC/GAT | 1217 | 406 | Gly/Asp | Published 2009 | India | Sequencing | Whole gene | EHR | 3ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB G358V, E368Q, S380D, P397T, G448V; embC I287L, W326R" | - |
| Ramaswamy SV AAC 2000 | GGC/GAC | 1217 | 406 | Gly/Asp | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 40ug/ml | BACTEC 460, agar diffusion method | 75/108 | 1/0 | Asp4Asn in embA | ![]() |
| Ramaswamy SV AAC 2000 | GGC/GCC | 1217 | 406 | Gly/Ala | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 20ug/ml | BACTEC 460, agar diffusion method | 75/108 | 2/0 | In one of the isolates, -11 C/A in embA and Met306Ile in embB. | - |
| Srivastava S CurrMicro 2006 | GGC/GCG | 1190 | 406 | Gly/Ala | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 32ug/ml | Proportion method | 23/23 | 1/0 | Met306Val, Glu368Ala, and Ser380Arg on embB. R/Tot and R/S calculated from Table 1. | - |
| Lee AS AAC 2004 | ATG/ATA | 1269 | 423 | Met/Ile | Published 2004 | Singapore | Sequencing | Whole gene | EI | N.S. | BACTEC 460 | 25/45 | 1/0 | None in region amplified (see Gene coverage). | - |
| Srivastava S JMM 2009 | CCG/CTG | 1289 | 430 | Pro/Leu | Published 2009 | India | Sequencing | Whole gene | EHR | 2ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB G406D, A431T; embC I297T" | - |
| Srivastava S JMM 2009 | GCG/ACC | 1291-1293 | 431 | Ala/Thr | Published 2009 | India | Sequencing | Whole gene | EHR | 2ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB G406D,P430L; embC I297T" | - |
| Srivastava S JMM 2009 | GCG/GGC | 1301-1302 | 434 | Arg/Gly | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306L, A356V, S366P, W395R, V435G, V436G, T437A; embC T270I" | - |
| Srivastava S JMM 2009 | GTG/GGC | 1304-1305 | 435 | Val/Gly | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306L, A356V, S366P, W395R, A434G, V436G, T437A; embC T270I" | - |
| Srivastava S JMM 2009 | GTG/GGC | 1307-1308 | 436 | Val/Gly | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306L, A356V, S366P, W395R, A434G, V435G, T437A; embC T270I" | - |
| Srivastava S JMM 2009 | ACC/GCG | 1309-1311 | 437 | Thr/Ala | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306L, A356V, S366P, W395R, A434G, V435G, V436G; embC T270I" | - |
| Srivastava S CurrMicro 2006 | CCG/CAT | 1337-1338 | 446 | Pro/His | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 2ug/ml | Proportion method, E-Test | 23/23 | 1/0 | "Asp299Glu, Glu378Ala, and Ile465Asp in embB; Thr270Ile and 254 Synonymous (GCC/GCG) in embC. R/T and R/S calculated from Table 1." | - |
| Srivastava S JMM 2009 | GGC/GTG | 1343-1344 | 448 | Gly/Val | Published 2009 | India | Sequencing | Whole gene | EHR | 3ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB G358V, E368Q, S380D, P397T, G406D; embC I287L, W326R" | - |
| Srivastava S JMM 2009 | GTG/CTG | 1354 | 452 | Val/Leu | Published 2009 | India | Sequencing | Whole gene | EHR | 256ug/ml | Proportion method, E-Test | 44/44 | 1/0 | embB L239P, Y315L, N318S, E378A, Y384N, N400K | - |
| Srivastava S JMM 2009 | GGC/GCG | 1376-1377 | 459 | Gly/Ala | Published 2009 | India | Sequencing | Whole gene | EHR | 32ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306V, N318K, N368A, S380R, P397Q, R460C; embR T32P, D53H" | - |
| Srivastava S JMM 2009 | CGT/TGC | 1378-1380 | 460 | Arg/Cys | Published 2009 | India | Sequencing | Whole gene | EHR | 6ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB E368A, S380R, P397Q; embC A244T, G288W, V303G embR L172R" | - |
| Srivastava S JMM 2009 | CGT/CTG | 1379-1380 | 460 | Arg/Leu | Published 2009 | India | Sequencing | Whole gene | EHR | 4ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB S347I, E368D; embC I297T; embR R230W, I396T" | - |
| Srivastava S JMM 2009 | CCG/AGC | 1381-1383 | 461 | Pro/Ser | Published 2009 | India | Sequencing | Whole gene | EHR | 128ug/ml | Proportion method, E-Test | 44/44 | 1/0 | "embB M306V, V309G, A310R, D311R, V369A, P375A, F398Y; embC T270I; embR G240R" | - |
| Srivastava S CurrMicro 2006 | ATT/GAT | 1393-1394 | 465 | Ile/Asp | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 2ug/ml | Proportion method, E-Test | 23/23 | 1/0 | "Asp299Glu, Glu378Ala, and Pro446His in embB; Thr270Ile and 254 Synonymous (GCC/GCG) in embC. R/T and R/S calculated from Table 1." | - |
| Srivastava S CurrMicro 2006 | CGT/CCG | 1406-1407 | 469 | Arg/Pro | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 2ug/ml | Proportion method, E-Test | 23/23 | 1/0 | Asp299Glu, Glu378Ala, and Arg471Pro in embB. R/T and R/S calculated from Table 1. | - |
| Srivastava S CurrMicro 2006 | CGT/CCG | 1412-1413 | 471 | Arg/Pro | Published 2006 | India | Sequencing | ERDR | E, EHR, HR, EH | 2ug/ml | Proportion method, E-Test | 23/23 | 1/0 | Asp299Glu, Glu378Ala, and Arg469Pro in embB. R/T and R/S calculated from Table 1. | - |
| Ramaswamy SV AAC 2000 | CAG/CGG | 1490 | 497 | Gln/Arg | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 30-50ug/ml | BACTEC 460, agar diffusion method | 75/108 | 3/0 | In one of the isolates: -12 C/T in embA, Ser501Trp in iniA. | ![]() |
| Ramaswamy SV AAC 2000 | CAG/AAG | 1490 | 497 | Gln/Lys | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 30-50ug/ml | BACTEC 460, agar diffusion method | 75/108 | 2/0 | "-12 C/T in embA at MIC=30ug/ml; -89 C/T in iniB at MIC>50ug/ml." | - |
| Sreevatsan S AAC 1997 | ACC/ATC | 1889 | 630 | Thr/Ile | Published 1997 | USA, Mexico, Europe, Yemen, the Philippines, Japan, India | PCR-SSCP, Sequencing | Whole gene | E | >40ug/ml | BACTEC 460, agar diffusion method | 69/99 | 2/0 | - | - |
| Lee AS AAC 2004 | GCG/ACG | 1975 | 659 | Ala/Thr | Published 2004 | Singapore | Sequencing | Whole gene | ES | N.S. | BACTEC 460 | 25/45 | 0/1 | None in region amplified (see Gene coverage). | - |
| Ramaswamy SV AAC 2000 | GGC/GAC | 2234 | 745 | Gly/Asp | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 40ug/ml | BACTEC 460, agar diffusion method | 75/108 | 1/0 | Gly308Arg in iniA | - |
| Ramaswamy SV AAC 2000 | GAC/GCC | 2876 | 959 | Asp/Ala | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 10-50ug/ml | BACTEC 460, agar diffusion method | 75/108 | 1/0 | - | - |
| Ramaswamy SV AAC 2000 | ATG/AGG | 2999 | 1000 | Met/Arg | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 10-50ug/ml | BACTEC 460, agar diffusion method | 75/108 | 1/0 | - | - |
| Ramaswamy SV AAC 2000 | GAC/AAC | 3070 | 1024 | Asp/Asn | Published 2000 | USA, Russia | Sequencing | Whole gene | E | 10-50ug/ml | BACTEC 460, agar diffusion method | 75/108 | 1/0 | - | - |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |